- Record: found
- Abstract: not found
- Article: not found
SWOG 0514: a phase II study of sorafenib (BAY43-9006) as single agent in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinomas
Read this article at
ScienceOpen
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.